Rocket Pharmaceuticals to acquire Renovacor 20-Sep-2022 By Rachel Arthur Rocket Pharmaceuticals, a late-stage, clinical biotech advancing a pipeline of genetic therapies for rare childhood disorders, will acquire Renovacor: helping it strengthen its position in AAV-based cardiac gene therapy.
